Author

D. M. Nanus

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:genetic perturbation / CRISPR· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

A. Berger· 1 shared A. Flesken-Nikitin· 1 shared A. Y. Nikitin· 1 shared B. Lu· 1 shared C. C. Au· 1 shared C.-Y. Cheng· 1 shared D. S. Rickman· 1 shared D. Worroll· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Berger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in Castrate-Resistant Prostate Cancer

S. Kim, M. A. B. Jamalruddin, C. C. Au, E. Mukhtar, L. Portella, A. Berger, D. Worroll, D. S. Rickman, D. M. Nanus, P. Giannakakou

This study identifies unique nuclear import and chromatin engagement mechanisms of AR-V7 in castrate-resistant prostate cancer, suggesting a Hit-and-Run transcriptional mode.

bioRxiv · Jun 3, 2021Cancer Biology

Membrane metalloendopeptidase suppresses prostate carcinogenesis by attenuating effects of gastrin-releasing peptide on stem/progenitor cells

C.-Y. Cheng, Z. Zhou, M. Stone, B. Lu, A. Flesken-Nikitin, D. M. Nanus, A. Y. Nikitin

This study shows MME suppresses prostate cancer by inhibiting GRP/GRPR signaling in stem/progenitor cells, and identifies GRPR as a therapeutic target in MME-low cancers.

bioRxiv · Dec 23, 2019Cancer Biology